These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26901531)

  • 21. Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production.
    Ter Braak B; Siezen CL; Lee JS; Rao P; Voorhoeve C; Ruppin E; van der Laan JW; van de Water B
    Breast Cancer Res; 2017 Feb; 19(1):14. PubMed ID: 28173837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discrepancies in insulin-like growth factor signaling? No, not really.
    Conover CA
    Growth Horm IGF Res; 2016; 30-31():42-44. PubMed ID: 27792888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterozygous mutation within a kinase-conserved motif of the insulin-like growth factor I receptor causes intrauterine and postnatal growth retardation.
    Kruis T; Klammt J; Galli-Tsinopoulou A; Wallborn T; Schlicke M; Müller E; Kratzsch J; Körner A; Odeh R; Kiess W; Pfäffle R
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1137-42. PubMed ID: 20103656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor 1 receptor signaling regulates embryonic epicardial cell proliferation through focal adhesion kinase pathway.
    Yan Y; Qin Q; Wu L; Jing X; Deng S; She Q
    Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):976-983. PubMed ID: 30184089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells.
    Osuka S; Sampetrean O; Shimizu T; Saga I; Onishi N; Sugihara E; Okubo J; Fujita S; Takano S; Matsumura A; Saya H
    Stem Cells; 2013 Apr; 31(4):627-40. PubMed ID: 23335250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer.
    De Martino MC; van Koetsveld PM; Feelders RA; de Herder WW; Dogan F; Janssen JAMJL; Hofste Op Bruinink D; Pivonello C; Waaijers AM; Colao A; de Krijger RR; Pivonello R; Hofland LJ
    Endocrine; 2019 Jun; 64(3):673-684. PubMed ID: 30838516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation.
    Huang CT; Chang MC; Chen YL; Chen TC; Chen CA; Cheng WF
    Cancer Lett; 2015 Apr; 359(1):117-26. PubMed ID: 25592043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGF1R undergoes active and directed centripetal transport on filopodia upon receptor activation.
    Krndija D; Fairhead M
    Biochem J; 2019 Dec; 476(23):3583-3593. PubMed ID: 31738383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral pain is enhanced by insulin-like growth factor 1 and its receptors in a mouse model of type 2 diabetes mellitus.
    Tang Z; Cao F; Zhang H; Tang J; Li H; Zhang Y; Feng B; Wang H
    J Diabetes; 2019 Apr; 11(4):309-315. PubMed ID: 30105862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H; Pelzer AM; Kiang DT; Yee D
    Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel human monoclonal antibodies to insulin-like growth factor (IGF)-II that potently inhibit the IGF receptor type I signal transduction function.
    Feng Y; Zhu Z; Xiao X; Choudhry V; Barrett JC; Dimitrov DS
    Mol Cancer Ther; 2006 Jan; 5(1):114-20. PubMed ID: 16432169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of beta-catenin signaling.
    Wang L; Shao YY; Ballock RT
    J Bone Miner Res; 2010 May; 25(5):1138-46. PubMed ID: 20200966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells.
    Riedemann J; Sohail M; Macaulay VM
    Biochem Biophys Res Commun; 2007 Apr; 355(3):700-6. PubMed ID: 17320820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
    Ricort JM; Binoux M
    Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models.
    Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ
    J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HASF (C3orf58) is a novel ligand of the insulin-like growth factor 1 receptor.
    Bareja A; Hodgkinson CP; Payne AJ; Pratt RE; Dzau VJ
    Biochem J; 2017 Feb; 474(5):771-780. PubMed ID: 28096202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A heterozygous mutation of the insulin-like growth factor-I receptor causes retention of the nascent protein in the endoplasmic reticulum and results in intrauterine and postnatal growth retardation.
    Wallborn T; Wüller S; Klammt J; Kruis T; Kratzsch J; Schmidt G; Schlicke M; Müller E; van de Leur HS; Kiess W; Pfäffle R
    J Clin Endocrinol Metab; 2010 May; 95(5):2316-24. PubMed ID: 20357178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
    Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ
    Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor signaling regulates zebrafish embryonic growth and development by promoting cell survival and cell cycle progression.
    Schlueter PJ; Peng G; Westerfield M; Duan C
    Cell Death Differ; 2007 Jun; 14(6):1095-105. PubMed ID: 17332774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.